Is Randomization to Placebo Safe? Risk in Placebo-Controlled Angina Trials: Angina Risk Meta-Analysis | Zendy

Stephen P. Glasser | Zendy; James Willard | Zendy; Albert DeFelice | Zendy; John Lawrence | Zendy; James Hung | Zendy; Evelyn Obot | Zendy; John Girton | Zendy; Shari Targum | Zendy; Douglas C. Throckmorton | Zendy; Dennis T. Mangano | Zendy; Raymond J. Lipicky | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Is Randomization to Placebo Safe? Risk in Placebo-Controlled Angina Trials: Angina Risk Meta-Analysis

Author(s) -

Stephen P. Glasser,

James Willard,

Albert DeFelice,

John Lawrence,

James Hung,

Evelyn Obot,

John Girton,

Shari Targum,

Douglas C. Throckmorton,

Dennis T. Mangano,

Raymond J. Lipicky

Publication year - 2011

Publication title -

cardiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.547

H-Index - 63

eISSN - 1421-9751

pISSN - 0008-6312

DOI - 10.1159/000335522

Subject(s) - placebo , angina , randomization , medicine , meta analysis , stable angina , randomized controlled trial , coronary heart disease , myocardial infarction , alternative medicine , pathology

It was the aim of this study to document the risks of symptomatic patients with angina in placebo-controlled, anti-anginal drug development trials in which symptom-limited exercise testing was used as the primary endpoint.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research